Perfusion MRI as the Predictive/prognostic and Pharmacodynamic Biomarkers in Recurrent Malignant Glioma Treated with Bevacizumab: A Systematic Review and a Time-To-Event Meta-Analysis

Author:Kyung Won Kim  Sang Hyun Choi  Seung Chai Jung  Ja Youn Lee  Ho Sung Kim  Seong Ho Park  

Session Type:Electronic Poster  

Session Date:Thursday, May 12, 2016  

Session:Human Brain Tumours 2: Response to Treatment  

Program Number:4359   

Presentation Time:13:30   

Room Number:Exhibition Hall   

Computer Number:Computer 20   

Predicting Overall Survival in Glioblastoma Patients from DTI, DCE and DSC MRI Data Acquired Prior to Surgery and Post-Chemoradiotherapy

Author:Lawrence Kenning  Martin Lowry  Martin Pickles  Chris Roland Hill  Shailendra Achawal  Chittoor Rajaraman  

Session Type:Electronic Poster  

Session Date:Thursday, May 12, 2016  

Session:Human Brain Tumours 2: Response to Treatment  

Program Number:4347   

Presentation Time:13:30   

Room Number:Exhibition Hall   

Computer Number:Computer 8   

Quantitative DCE-MRI for Differentiating High Grade Glioma Recurrence from Treatment-Related Changes:  Effect of T1 Mapping Method

Author:Greg Cron  Beckie Manouchehri  Andrew Boivin  Nader Zakhari  Brandon Zanette  Gerard Jansen  John Woulfe  Rebecca Thornhill  Andreas Greiser  Ian Cameron  Thanh Nguyen  

Session Type:Electronic Poster  

Session Date:Thursday, May 12, 2016  

Session:Human Brain Tumours 2: Response to Treatment  

Program Number:4354   

Presentation Time:13:30   

Room Number:Exhibition Hall   

Computer Number:Computer 15   

Which Is the Best Predictor for Histological Grade of Glioma: DWI, MRS, 11C-Methionine -, and 18F-Fluorodeoxyglucose -PET

Author:Keiichi Kikuchi  Yoshiyasu Hiratsuka  Shiro Ohue  Shohei Kohno  Teruhito Mochizuki  

Session Type:Electronic Poster  

Session Date:Thursday, May 12, 2016  

Session:Human Brain Tumours 2: Response to Treatment  

Program Number:4357   

Presentation Time:13:30   

Room Number:Exhibition Hall   

Computer Number:Computer 18